Biogen Inc.
Long
Updated

BIIB: Beaten Down BioTech Sector: On the Cusp of a Huge Wave 3

142
$9M shares bought by insider last Friday. Wave 3 Target of $403 matches Bull Flag Target.
Note
Today, BIIB price target was raised from $317 to $321 and announced partnership with another company to develop a new drug. The stock broke out. BB bands coiled and ready to snap and push stock price up on wave 3. Oscillators are closer to the oversold region and has lots of room to go up before being overbought.
snapshot
Note
snapshot
Note
Wave ((iii)) (Red) started.

snapshot

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.